Pump, pipes, and filter: do SGLT2 inhibitors cover it all?

被引：57

作者：

Verma, Subodh ^{[1
,2
]}

Juni, Peter ^{[2
]}

Mazer, C. David ^{[2
]}

机构：

[1] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, Toronto, ON M5B 1W8, Canada

[2] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON, Canada

来源：

LANCET | 2019年 / 393卷 / 10166期

关键词：

EMPAGLIFLOZIN; MORTALITY; DISEASE;

D O I：

10.1016/S0140-6736(18)32824-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3 / 5

页数：3

共 11 条

[1]

[Anonymous], LANCET

[2] Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change [J].

Cornell, John E. ;

Mulrow, Cynthia D. ;

Localio, Russell ;

Stack, Catharine B. ;

Meibohm, Anne R. ;

Guallar, Eliseo ;

Goodman, Steven N. .

ANNALS OF INTERNAL MEDICINE, 2014, 160 (04) :267-270

[3]

Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI [10.2337/dci18-0033, 10.1007/s00125-018-4729-5]

[4] Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980793 adults from 68 prospective studies [J].

Gnatiuc, Louisa ;

Herrington, William G. ;

Halsey, Jim ;

Tuomilehto, Jaakko ;

Fang, Xianghau ;

Kim, Hyeon C. ;

DeBacquer, Dirk ;

Dobson, Annette J. ;

Criqui, Michael H. ;

Jacobs, David R., Jr. ;

Leon, David A. ;

Peters, Sanne A. E. ;

Ueshima, Hirotsugu ;

Sherliker, Paul ;

Peto, Richard ;

Collins, Rory ;

Huxley, Rachel R. ;

Emberson, Jonathan R. ;

Woodward, Mark ;

Lewington, Sarah ;

De Backer, G. ;

De Bacquer, D. ;

Kornitzer, M. ;

Morris, R. ;

Wannamethee, S. G. ;

Whincup, P. ;

Law, M. ;

Morris, J. ;

Wald, N. ;

Kromhout, D. ;

Benetos, A. ;

Guize, L. ;

Jensen, G. ;

Schnohr, P. ;

Jousilahti, P. ;

Puska, P. ;

Tuomilehto, J. ;

Vartiainen, E. ;

Aromaa, A. ;

Knekt, P. ;

Reunanen, A. ;

Johansen, N. Borup ;

Thomsen, T. ;

Bengtsson, C. ;

Bjorkelund, C. ;

Lissner, L. ;

Goldbourt, U. ;

Selmer, R. ;

Tverdal, A. ;

Meade, T. .

LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (07) :538-546

[5] Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored [J].

McMurray, John J. V. ;

Gerstein, Hertzel C. ;

Holman, Rury R. ;

Pfeffer, Marc A. .

LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (10) :843-851

[6] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes [J].

Neal, Bruce ;

Perkovic, Vlado ;

Mahaffey, Kenneth W. ;

de Zeeuw, Dick ;

Fulcher, Greg ;

Erondu, Ngozi ;

Shaw, Wayne ;

Law, Gordon ;

Desai, Mehul ;

Matthews, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :644-657

[7] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes [J].

Rawshani, Aidin ;

Rawshani, Araz ;

Franzen, Stefan ;

Eliasson, Bjorn ;

Svensson, Ann-Marie ;

Miftaraj, Mervete ;

McGuire, Darren K. ;

Sattar, Naveed ;

Rosengren, Annika ;

Gudbjornsdottir, Soffia .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15) :1407-1418

[8] SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review [J].

Verma, Subodh ;

McMurray, John J. V. .

DIABETOLOGIA, 2018, 61 (10) :2108-2117

[9]

Wanner C, 2016, NEW ENGL J MED, V375, P1801, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]

[10]

Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI [10.1056/NEJMoa1812389, 10.1056/NEJMc1902837]

← 1 2 →